~402 spots leftby Sep 2026

ePRO Monitoring for Chronic Disease Care Transitions

Recruiting in Palo Alto (17 mi)
+1 other location
AD
Overseen byAnuj K Dalal, MD
Age: 18+
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Recruiting
Sponsor: Brigham and Women's Hospital
Disqualifiers: Less than 18, Less than two conditions, others
No Placebo Group

Trial Summary

What is the purpose of this trial?

This study aims to predict and minimize post-discharge adverse events (AEs) during care transitions through early identification and escalation of patient-reported symptoms to inpatient and ambulatory clinicians by way of predictive algorithms and clinically integrated digital health apps. We will (1) develop and prospectively validate a predictive model of post-discharge AEs for patients with multiple chronic conditions (MCC); (2) combine, adapt, extend, and iteratively refine our EHR-integrated digital health infrastructure in a series of design sessions with patient and clinician participants; (3) conduct a RCT to evaluate the impact of ePRO monitoring on post-discharge AEs for MCC patients discharged from the general medicine service across Brigham Health; and (4) use mixed methods to evaluate barriers and facilitators of implementation and use as we develop a plan for sustainability, scale, and dissemination.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

What data supports the effectiveness of the ePRO Application treatment for chronic disease care transitions?

Research shows that using telecommunications and surveillance technologies in care transitions can help monitor patients' conditions after hospital discharge, reducing the risk of negative health outcomes. This suggests that the ePRO Application, which likely uses similar technology, could be effective in improving care transitions for patients with chronic diseases.12345

Is the ePRO Monitoring for Chronic Disease Care Transitions generally safe for humans?

The research articles focus on medication safety during care transitions and suggest that electronic tools, like medication reconciliation applications, can help reduce risks associated with medication discrepancies. While these studies do not directly address the safety of ePRO Monitoring, they indicate that electronic interventions in care transitions are generally aimed at improving safety.678910

How is the ePRO Application treatment different from other treatments for chronic disease care transitions?

The ePRO Application is unique because it uses electronic patient-reported outcomes to monitor patients' conditions after they leave the hospital, helping to prevent negative health outcomes by keeping healthcare providers informed and engaged in real-time.3451112

Research Team

AD

Anuj K Dalal, MD

Principal Investigator

Brigham and Women's Hospital

Eligibility Criteria

This trial is for adults with two or more chronic conditions like heart disease, diabetes, COPD, etc., who are hospitalized and will be discharged to home or a facility. They must speak English or have an English-speaking healthcare proxy.

Inclusion Criteria

I have two or more chronic conditions from a specified list.
Non-English-speaking patients who have an English-speaking legally designated healthcare proxy or next of kin (i.e., a family caregiver)
I or my healthcare proxy can communicate in English.
See 3 more

Exclusion Criteria

No identifiable healthcare proxy or next of kin (i.e., a family caregiver)
Less than two chronic conditions
I was in the hospital for less than a day.
See 1 more

Trial Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Baseline Pre-implementation

Development and validation of a predictive model of post-discharge AEs for MCC patients using PRO questionnaires and EHR-derived variables

18 months

Main Trial (RCT) Period

Randomized controlled trial comparing real-time symptom monitoring intervention to usual care for patients with MCCs transitioning out of the hospital

30 months

Follow-up

Participants are monitored for safety and effectiveness after discharge, focusing on adverse events and healthcare utilization

4 weeks

Treatment Details

Interventions

  • ePRO Application (Behavioral Intervention)
Trial OverviewThe study tests an ePRO application designed to monitor symptoms in real-time and predict adverse events after patients with multiple chronic conditions leave the hospital. It involves developing predictive models and integrating them into digital health apps.
Participant Groups
3Treatment groups
Experimental Treatment
Active Control
Group I: Intervention (Arm 3)Experimental Treatment1 Intervention
During the 30-month Main Trial (RCT) Period, patients will be randomized to the intervention (Arm 3, n=425). Data collection for post-discharge AE determination will occur during both periods.
Group II: Usual Care (Arm 1)Active Control1 Intervention
During the 18-month Baseline Period (Arm 1, n=450) patients will be enrolled and receive usual care to develop the initial predictive model.
Group III: Usual Care (Arm 2)Active Control1 Intervention
During the 30-month Main Trial (RCT) Period, patients will be randomized to usual care (Arm 2, n=425). Data collection for post-discharge AE determination will occur during both periods.

Find a Clinic Near You

Who Is Running the Clinical Trial?

Brigham and Women's Hospital

Lead Sponsor

Trials
1,694
Recruited
14,790,000+
Dr. William Curry profile image

Dr. William Curry

Brigham and Women's Hospital

Chief Medical Officer

MD from Columbia University College of Physicians and Surgeons

Dr. Scott Schissel profile image

Dr. Scott Schissel

Brigham and Women's Hospital

Chief Executive Officer since 2021

MD from Columbia University College of Physicians and Surgeons

RAND

Collaborator

Trials
145
Recruited
617,000+
Rand Sutherland profile image

Rand Sutherland

RAND

Chief Medical Officer since 2024

MD from University of Chicago

Jason Matheny

RAND

Chief Executive Officer since 2022

PhD in Public Policy, Harvard University

Findings from Research

The implementation of EHR-integrated digital health tools, including a checklist and video for discharge preparation, did not significantly increase patient activation levels at discharge, with only a slight increase observed (59.8% vs 56.7%).
Patients using the digital tools experienced a significantly longer average length of stay in the hospital (10.13 days) compared to those who did not use the tools (6.21 days), suggesting that while the tools may have helped identify patient concerns, they did not improve discharge outcomes.
Evaluation of electronic health record-integrated digital health tools to engage hospitalized patients in discharge preparation.Dalal, AK., Piniella, N., Fuller, TE., et al.[2022]
A new measurement instrument was developed to assess the quality of care transitions and patient safety during hospital discharge, based on input from nurses and validated by a committee of experts.
The instrument consists of 37 items across six domains, achieving a high Content Validity Index of 0.93, indicating strong agreement on its relevance and importance for improving patient safety in Brazil.
Development of a measurement instrument to assess patient safe transition at hospital discharge.Acosta, AM., Lima, MADDS., Marques, GQ., et al.[2023]
Tele-transitions of care interventions significantly reduce readmission rates (by 41%) and mortality rates (by 28%) in older adults at high risk for readmission, based on a systematic review of 14 studies involving randomized controlled trials.
These interventions also improve health-related quality of life, although they do not significantly reduce emergency department visits or improve functional status, indicating a targeted benefit in managing post-discharge health outcomes.
The effectiveness of tele-transitions of care interventions in high-risk older adults: A systematic review and meta-analysis.Soh, YY., Zhang, H., Toh, JJY., et al.[2023]

References

Evaluation of electronic health record-integrated digital health tools to engage hospitalized patients in discharge preparation. [2022]
Development of a measurement instrument to assess patient safe transition at hospital discharge. [2023]
The effectiveness of tele-transitions of care interventions in high-risk older adults: A systematic review and meta-analysis. [2023]
Use of participatory visual narrative methods to explore older adults' experiences of managing multiple chronic conditions during care transitions. [2019]
Influence of a transitional care clinic on subsequent 30-day hospitalizations and emergency department visits in individuals discharged from a skilled nursing facility. [2013]
Understanding Hazards for Adverse Drug Events Among Older Adults After Hospital Discharge: Insights From Frontline Care Professionals. [2023]
An electronic pillbox intervention designed to improve medication safety during care transitions: challenges and lessons learned regarding implementation and evaluation. [2022]
Interventions to improve patient safety in transitional care--a review of the evidence. [2018]
Effect of an electronic medication reconciliation application and process redesign on potential adverse drug events: a cluster-randomized trial. [2022]
Evaluation of an Electronic Module for Reconciling Medications in Home Health Plans of Care. [2018]
Transitions between SNF and home-based care in patients with multiple sclerosis. [2022]
12.United Statespubmed.ncbi.nlm.nih.gov
An electronic health record-based intervention to increase follow-up office visits and decrease rehospitalization in older adults. [2022]